Target Drug Exposure Attainment in Children: How to Get from Better to Best.
作者信息
Flint Robert B, Allegaert Karel
机构信息
Department of Pediatrics, Division Neonatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
出版信息
Paediatr Drugs. 2020 Aug;22(4):445-447. doi: 10.1007/s40272-020-00402-6.
Abstract
摘要
相似文献
1
Target Drug Exposure Attainment in Children: How to Get from Better to Best.
Paediatr Drugs. 2020 Aug;22(4):445-447. doi: 10.1007/s40272-020-00402-6.
2
External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.
Paediatr Drugs. 2020 Aug;22(4):433-444. doi: 10.1007/s40272-020-00400-8.
3
Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss.
J Pediatr. 2003 Jan;142(1):41-6. doi: 10.1067/mpd.2003.mpd037.
4
A comparative trial of tobramycin vs gentamicin in combination with vancomycin and nystatin for alimentary tract suppression in leukemic patients.
Eur J Cancer (1965). 1979;15 Suppl:35-44.
5
Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board?
J Antimicrob Chemother. 2017 Mar 1;72(3):801-804. doi: 10.1093/jac/dkw495.
6
Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates.
J Antimicrob Chemother. 2015 Jul;70(7):2074-7. doi: 10.1093/jac/dkv052. Epub 2015 Mar 12.
7
Effective bactericidal activity of tobramycin and vancomycin eluted from acrylic bone cement.
Acta Orthop Scand. 2001 Jun;72(3):237-40. doi: 10.1080/00016470152846547.
8
Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net.
J Antimicrob Chemother. 1997 Mar;39(3):355-61. doi: 10.1093/jac/39.3.355.
9
Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children.
Pediatr Crit Care Med. 2018 Jun;19(6):e263-e269. doi: 10.1097/PCC.0000000000001474.
10
Detectable Concentrations of Inhaled Tobramycin in Critically Ill Children Without Cystic Fibrosis: Should Routine Monitoring Be Recommended?
Pediatr Crit Care Med. 2017 Dec;18(12):e615-e620. doi: 10.1097/PCC.0000000000001362.
引用本文的文献
1
Evaluating Adherence to Therapeutic Drug Monitoring Guidelines for Gentamicin in Neonatal Care: A Retrospective Study at the Maternity and Children's Hospital in Makkah.
Children (Basel). 2024 Jan 15;11(1):100. doi: 10.3390/children11010100.
2
Stratified Management for Bacterial Infections in Late Preterm and Term Neonates: Current Strategies and Future Opportunities Toward Precision Medicine.
Front Pediatr. 2021 Apr 1;9:590969. doi: 10.3389/fped.2021.590969. eCollection 2021.
本文引用的文献
1
External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.
Paediatr Drugs. 2020 Aug;22(4):433-444. doi: 10.1007/s40272-020-00400-8.
2
Pharmacometrics and Machine Learning Partner to Advance Clinical Data Analysis.
Clin Pharmacol Ther. 2020 Apr;107(4):926-933. doi: 10.1002/cpt.1774. Epub 2020 Feb 17.
3
Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.
Expert Opin Drug Metab Toxicol. 2019 Sep;15(9):735-749. doi: 10.1080/17425255.2019.1655540. Epub 2019 Aug 19.
4
An evaluation of the user-friendliness of Bayesian forecasting programs in a clinical setting.
Br J Clin Pharmacol. 2019 Oct;85(10):2436-2441. doi: 10.1111/bcp.14066. Epub 2019 Aug 6.
5
Larger Dose Reductions of Vancomycin Required in Neonates with Patent Ductus Arteriosus Receiving Indomethacin versus Ibuprofen.
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00853-19. Print 2019 Aug.
6
Model-Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities.
CPT Pharmacometrics Syst Pharmacol. 2018 Dec;7(12):785-787. doi: 10.1002/psp4.12353. Epub 2018 Oct 16.
7
Developmental Changes in Pharmacokinetics and Pharmacodynamics.
J Clin Pharmacol. 2018 Oct;58 Suppl 10:S10-S25. doi: 10.1002/jcph.1284.
8
The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review.
Paediatr Drugs. 2018 Apr;20(2):153-164. doi: 10.1007/s40272-018-0282-4.
9
Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based Approach.
J Pediatric Infect Dis Soc. 2019 May 11;8(2):97-104. doi: 10.1093/jpids/pix109.
10
Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.
Antimicrob Agents Chemother. 2015 Dec 7;60(2):1013-21. doi: 10.1128/AAC.01968-15. Print 2016 Feb.
Zotero 插件